Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
AK Mitra, PR Velagaleti, S Natesan - US Patent 8,435,544, 2013 - Google Patents
The embodiments disclosed herein relate to ophthalmic com positions comprising
calcineurin inhibitors or mTOR inhibi tors, and more particularly to methods for treating an …
calcineurin inhibitors or mTOR inhibi tors, and more particularly to methods for treating an …
Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
AK Mitra, PR Velagaleti, S Natesan - US Patent 8,535,694, 2013 - Google Patents
The embodiments disclosed herein relate to ophthalmic compositions comprising
calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an …
calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an …
Synthesis of diethyl {[5-(3-fluorophenyl)-pyridine-2yl] methyl} phosphonate
KH Yong, IA Zavialov, J Yin, X Fu… - US Patent …, 2010 - Google Patents
This application is based on and claims the priority of US As described in the 324
application mentioned herein Provisional Application No. 60/817,867 filed Jun. 30, 2006 …
application mentioned herein Provisional Application No. 60/817,867 filed Jun. 30, 2006 …
CO2 mineralization in produced and industrial effluent water by pH-swing carbonation
US11230473B2 - CO2 mineralization in produced and industrial effluent water by pH-swing
carbonation - Google Patents US11230473B2 - CO2 mineralization in produced and industrial …
carbonation - Google Patents US11230473B2 - CO2 mineralization in produced and industrial …
Ophthalmic compositions
AK Mitra, PR Velagaleti, S Natesan - US Patent 10,973,871, 2021 - Google Patents
Int. Cl. A61K 38/13(2006.01) A61K 9/00(2006.01) A61K 9/107(2006.01) A61K
31/436(2006.01) A61K 4732(2006.01) A61K 31/355(2006.01) A61K 31/56(2006.01)(52) US …
31/436(2006.01) A61K 4732(2006.01) A61K 31/355(2006.01) A61K 31/56(2006.01)(52) US …
Ophthalmic compositions
AK Mitra, PR Velagaleti, S Natesan - US Patent 10,265,375, 2019 - Google Patents
The embodiments disclosed herein relate to ophthalmic compositions comprising
calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an …
calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an …
Hydrosilylation reaction inhibitors, and use thereof for preparing stable curable silicone compositions
S Marrot, Y Maadadi - US Patent 9,120,935, 2015 - Google Patents
US9120935B2 - Hydrosilylation reaction inhibitors, and use thereof for preparing stable
curable silicone compositions - Google Patents US9120935B2 - Hydrosilylation reaction …
curable silicone compositions - Google Patents US9120935B2 - Hydrosilylation reaction …
Efficient integration of manufacturing of upcycled concrete product into power plants
A manufacturing process of a concrete product includes:(1) extracting calcium from solids as
portlandite;(2) forming a cementitious slurry including the portlandite;(3) shaping the …
portlandite;(2) forming a cementitious slurry including the portlandite;(3) shaping the …
Mitigation of alkali-silica reaction in concrete using readily-soluble chemical additives
GD Falzone, T Oey, W Franke, P Seiler… - US Patent …, 2023 - Google Patents
Abstract A manufacturing method includes:(1) incorporating at least one soluble, calcium,
magnesium, or other divalent cation-containing additive into a concrete mixture including …
magnesium, or other divalent cation-containing additive into a concrete mixture including …
Protocol for treatment of lupus nephritis
N Solomons, RB Huizinga - US Patent 11,622,991, 2023 - Google Patents
A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, eg
fungichromin having five-membered rings with one oxygen as the only ring hetero atom, eg …
fungichromin having five-membered rings with one oxygen as the only ring hetero atom, eg …